請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36002
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 符文美 | |
dc.contributor.author | Hsien-Yu Hsiao | en |
dc.contributor.author | 蕭嫺毓 | zh_TW |
dc.date.accessioned | 2021-06-13T07:49:29Z | - |
dc.date.available | 2005-08-02 | |
dc.date.copyright | 2005-08-02 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-25 | |
dc.identifier.citation | 參考文獻
Andersen, M., Overgaard, K., Meden, P., Boysen, G., & Choi, S. C. (1999). Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke, 30(7), 1464-1471. Asahi, M., Asahi, K., Wang, X., & Lo, E. H. (2000). Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab, 20(3), 452-457. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J. C., Moskowitz, M. A., et al. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci, 21(19), 7724-7732. Astrup, J., Siesjo, B. K., & Symon, L. (1981). Thresholds in cerebral ischemia - the ischemic penumbra. Stroke, 12(6), 723-725. Balduini, W., Mazzoni, E., Carloni, S., De Simoni, M. G., Perego, C., Sironi, L., et al. (2003). Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke, 34(8), 2007-2012. Bando, Y., Katayama, T., Kasai, K., Taniguchi, M., Tamatani, M., & Tohyama, M. (2003). GRP94 (94 kDa glucose-regulated protein) suppresses ischemic neuronal cell death against ischemia/reperfusion injury. Eur J Neurosci, 18(4), 829-840. Belayev, L., Busto, R., Ikeda, M., Rubin, L. L., Kajiwara, A., Morgan, L., et al. (1998). Protection against blood-brain barrier disruption in focal cerebral ischemia by the type Ⅳ phosphodiesterase inhibitor bbb022: A quantitative study. Brain Res, 787(2), 277-285. Block, F., Tondar, A., Schmidt, W., & Schwarz, M. (1997). Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats. Neuroreport, 8(17), 3829-3832. Bowes, M. P., Rothlein, R., Fagan, S. C., & Zivin, J. A. (1995). Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology, 45(4), 815-819. Carling, D. (2004). The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci, 29(1), 18-24. Chan, P. H. (2001). Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab, 21(1), 2-14. Clark, A. W., Krekoski, C. A., Bou, S. S., Chapman, K. R., & Edwards, D. R. (1997). Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett, 238(1-2), 53-56. Clough-Helfman, C., & Phillis, J. W. (1990). 5-aminoimidazole-4-carboxamide riboside (AICAR) administration reduces cerebral ischemic damage in the Mongolian gerbil. Brain Res Bull, 25(1), 203-206. Culmsee, C., Monnig, J., Kemp, B. E., & Mattson, M. P. (2001). AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci, 17(1), 45-58. Davies, S. P., Carling, D., & Hardie, D. G. (1989). Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem, 186(1-2), 123-128. Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci, 22(9), 391-397. Emsley, H. C., & Tyrrell, P. J. (2002). Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab, 22(12), 1399-1419. Fiskum, G., Murphy, A. N., & Beal, M. F. (1999). Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab, 19(4), 351-369. Fiskum, G., Starkov, A., Polster, B. M., & Chinopoulos, C. (2003). Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann N Y Acad Sci, 991, 111-119. Folcik, V. A., Smith, T., O'Bryant, S., Kawczak, J. A., Zhu, B., Sakurai, H., et al. (1999). Treatment with bbb022a or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type Ⅳ phosphodiesterase inhibitors. J Neuroimmunol, 97(1-2), 119-128. Garcia-Gil, M., Pesi, R., Perna, S., Allegrini, S., Giannecchini, M., Camici, M., et al. (2003). 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience, 117(4), 811-820. Harkness, K. A., Adamson, P., Sussman, J. D., Davies-Jones, G. A., Greenwood, J., & Woodroofe, M. N. (2000). Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain, 123 (Pt 4), 698-709. Iadecola, C., Niwa, K., Nogawa, S., Zhao, X., Nagayama, M., Araki, E., et al. (2001). Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate- mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A, 98(3), 1294-1299. Izaki, K., Kinouchi, H., Watanabe, K., Owada, Y., Okubo, A., Itoh, H., et al. (2001). Induction of mitochondrial heat shock protein 60 and 10 mRNAs following transient focal cerebral ischemia in the rat. Brain Res Mol Brain Res, 88(1-2), 14-25. Jung, J. E., Lee, J., Ha, J., Kim, S. S., Cho, Y. H., Baik, H. H., et al. (2004). 5-aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci Lett, 354(3), 197-200. Kato, H., Araki, T., Itoyama, Y., & Kogure, K. (1995). Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. Eur J Pharmacol, 272(1), 107-110. Keelan, J., Bates, T. E., & Clark, J. B. (1999). Heightened resistance of the neonatal brain to ischemia-reperfusion involves a lack of mitochondrial damage in the nerve terminal. Brain Res, 821(1), 124-133. Kim, H. Y., Singhal, A. B., & Lo, E. H. (2005). Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol, 57(4), 571-575. Klaidman, L., Morales, M., Kem, S., Yang, J., Chang, M. L., & Adams, J. D., Jr. (2003). Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology, 69(3), 150-157. Koketsu, N., Berlove, D. J., Moskowitz, M. A., Kowall, N. W., Caday, C. G., & Finklestein, S. P. (1994). Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol, 35(4), 451-457. Kokubo, Y., Matson, G. B., Derugin, N., Hill, T., Mancuso, A., Chan, P. H., et al. (2002). Transgenic mice expressing human copper-zinc superoxide dismutase exhibit attenuated apparent diffusion coefficient reduction during reperfusion following focal cerebral ischemia. Brain Res, 947(1), 1-8. Krieger, D. W., De Georgia, M. A., Abou-Chebl, A., Andrefsky, J. C., Sila, C. A., Katzan, I. L., et al. (2001). Cooling for acute ischemic brain damage (cool aid): An open pilot study of induced hypothermia in acute ischemic stroke. Stroke, 32(8), 1847-1854. Kroemer, G., & Reed, J. C. (2000). Mitochondrial control of cell death. Nat Med, 6(5), 513-519. Lapchak, P. A., Chapman, D. F., & Zivin, J. A. (2000). Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke, 31(12), 3034-3040. Latour, L. L., Kang, D. W., Ezzeddine, M. A., Chalela, J. A., & Warach, S. (2004). Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol, 56(4), 468-477. Lin, K. M., Lin, B., Lian, I. Y., Mestril, R., Scheffler, I. E., & Dillmann, W. H. (2001). Combined and individual mitochondrial hsp60 and hsp10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation, 103(13), 1787-1792. Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci, 4(5), 399-415. Mark, K. S., & Davis, T. P. (2002). Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol, 282(4), H1485-1494. Matsuo, Y., Mihara, S., Ninomiya, M., & Fujimoto, M. (2001). Protective effect of endothelin type a receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke, 32(9), 2143-2148. McCullough, L. D., Zeng, Z., Li, H., Landree, L. E., McFadden, J., & Ronnett, G. V. (2005). Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem, 280(21), 20493-20502. Meden, P., Overgaard, K., Sereghy, T., & Boysen, G. (1993). Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model. J Neurol Sci, 119(2), 209-216. Menge, T., Hartung, H. P., & Stuve, O. (2005). Statins--a cure-all for the brain? Nat Rev Neurosci, 6(4), 325-331. Musi, N., Hayashi, T., Fujii, N., Hirshman, M. F., Witters, L. A., & Goodyear, L. J. (2001). AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab, 280(5), E677-684. Nagai, N., Yamamoto, S., Tsuboi, T., Ihara, H., Urano, T., Takada, Y., et al. (2001). Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab, 21(6), 631-634. Nakai, T., Kano, S., Satoh, K., Hoshi, K., & Ichihara, K. (1996). Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. J Cardiovasc Pharmacol, 28(2), 264-270. Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., et al. (2001). The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med, 7(1), 59-64. Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998). Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke, 29(10), 2189-2195. Sharp, F. R., Massa, S. M., & Swanson, R. A. (1999). Heat-shock protein protection. Trends Neurosci, 22(3), 97-99. Shuaib, A., Yang, Y., Nakada, M. T., Li, Q., & Yang, T. (2002). Glycoprotein Ⅱb/Ⅲa antagonist, murine 7e3 f(Ab') 2, and tissue plasminogen activator in focal ischemia: Evaluation of efficacy and risk of hemorrhage with combination therapy. J Cereb Blood Flow Metab, 22(2), 215-222. Stoll, G. (2002). Inflammatory cytokines in the nervous system: Multifunctional mediators in autoimmunity and cerebral ischemia. Rev Neurol (Paris), 158(10 Pt 1), 887-891. Stolze, I., Berchner-Pfannschmidt, U., Freitag, P., Wotzlaw, C., Rossler, J., Frede, S., et al. (2002). Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood, 100(7), 2623-2628. Sumii, T., & Lo, E. H. (2002). Involvement of matrix metalloproteinase in thrombolysis- associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke, 33(3), 831-836. Tsuchiya, D., Hong, S., Matsumori, Y., Kayama, T., Swanson, R. A., Dillman, W. H., et al. (2003). Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery, 53(5), 1179-1187; discussion 1187-1178. Voos, W., & Rottgers, K. (2002). Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta, 1592(1), 51-62. Wachtel, M., Frei, K., Ehler, E., Fontana, A., Winterhalter, K., & Gloor, S. M. (1999). Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci, 112 (Pt 23), 4347-4356. Winder, W. W. (2001). Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol, 91(3), 1017-1028. Xu, R. X., Rocque, W. J., Lambert, M. H., Vanderwall, D. E., Luther, M. A., & Nolte, R. T. (2004). Crystal structures of the catalytic domain of phosphodiesterase 4b complexed with AMP, 8-Br-AMP, and rolipram. J Mol Biol, 337(2), 355-365. Yang, Y., Li, Q., & Shuaib, A. (2000). Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology, 39(5), 881-888. Yenari, M. A., Fink, S. L., Sun, G. H., Chang, L. K., Patel, M. K., Kunis, D. M., et al. (1998). Gene therapy with hsp72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol, 44(4), 584-591. Yepes, M., Sandkvist, M., Wong, M. K., Coleman, T. A., Smith, E., Cohan, S. L., et al. (2000). Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood, 96(2), 569-576. Zivin, J. A., & Mazzarella, V. (1991). Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol, 48(12), 1235-1238. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36002 | - |
dc.description.abstract | 摘要
由於中風的高致死率,在許多開發中及已開發國家高居十大死因第三名,且造成病患長久行動不便及家人負擔,然至今卻仍缺乏有效之治療方式。在本篇論文中,藉由將老鼠兩側總頸動脈及右側中大腦動脈結紮造成大腦局部缺血(ischemia),一個半小時後鬆開使血液回流(reperfusion),建立一個transient focal ischemia模式。8-Br-AMP是一個可通過細胞膜的adenine nucleotide analogue,在血液回流前5分鐘靜脈給予8-Br-AMP (10 mg/kg),24小時後經由TTC染色法發現其減少缺血-再灌流後腦損傷體積。另外,在血液灌流4小時後發現給予8-Br-AMP老鼠大腦皮質中萃取出較少的Evans Blue,顯示 8-Br-AMP減少了缺血-再灌流後增加的血腦障壁通透性。接著以西方點墨法發現在缺血-再灌流後24小時,血腦障壁的tight junction protein ZO-1表現減少,而給予8-Br-AMP的老鼠則部分抑制所減少的ZO-1,而另一個tight junction protein:occludin即使在缺血-再灌流後或給予8-Br-AMP都沒有明顯的變化。同時我們也發現8-Br-AMP減少腦梗塞後所誘導的COX-2表現,然而由RT-PCR發現,缺血-再灌流後所誘導的IL-1β mRNA似乎不受8-Br-AMP影響。此外,8-Br-AMP增加Hsp60 Mrna及蛋白質表現,顯示8-Br-AMP可能促進粒線體功能;此外,8-Br-AMP不影響缺血-再灌流後AMPK磷酸化程度。在SH-SY5Y細胞中,以hypoxia-reoxygenation模擬ischemia- reperfusion,發現給予8-Br-AMP可減少細胞死亡。而若在細胞中給予MPP+ (mitochondria complex І抑制劑)造成神經毒性, 利用MTT reaction、流式細胞儀,得知8-Br-AMP可抑制因粒線體功能缺失所導致的細胞死亡。綜合以上結果推斷, 8-Br-AMP可能經由減少血腦障壁通透性及粒線體功能喪失,於缺血-再灌流之動物模式中達到神經保護作用。 | zh_TW |
dc.description.abstract | Abstract
Estimated mortality of stroke is about 25%, which makes it the third major cause of death in industrialized countries. Due to the high rate of severe permanent disability, stroke is a burden not only for the affected patients but their families. Therefore, it is important to develop effective neuroprotectant. The occlusion of middle cerebral artery (MCA) and bilateral common carotid arteries was made in male Sprague–Dawley rats, and reperfusion was performed 1.5 h after the occlusion. 8-Br-AMP (10 mg/kg) was administered 5 minutes before the onset of reperfusion. The infarct volume of 8-Br-AMP-treated rats decreased 24 hours after MCA occlusion in comparison with control. Damage to the blood–brain barrier was judged by the extravasation of Evans blue dye, and the content of Evans Blue decreased in the rats treated with 8-Br-AMP. Western blots showed that the blood–brain barrier associated protein ZO-1 decreased after ischemia, which was partially antagonized by 8-Br-AMP. However, there was no detectable change in another blood–brain barrier associated protein, occludin. COX-2 expression also increased in response to ischemia-reperfusion, which was attenuated by 8-Br-AMP. Compared with sham group, the mRNA level of IL-1β increased after MCAO, and 8-Br-AMP did not significantly affect the mRNA expression of IL-1β. In addition, it was found that 8-Br-AMP increased the protein and mRNA level of Hsp60, which is important for mitochondrial protein folding and function. However, 8-Br-AMP did not significantly affect the phosphorylation of energy-sensitive protein, AMPK. To simulate pathophysiological ischemia/reperfusion, SH-SY5Y cells were exposed to hypoxia 24 hours and then reoxygenation 24 hours. Pretreatment of 8-Br-AMP led to the increase of the viability of SH-SY5Y cells after hypoxia/reoxygenation. In addition, pretreatment of cells with 8-Br-AMP antagonized mitochondrial dysfunction induced by MPP+. These results suggest that infusion with 8-Br-AMP resulted in reduction of injury after focal cerebral ischemia, and the protection was possibly due to the decreased disruption of blood–brain barrier and mitochondrial dysfunction. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T07:49:29Z (GMT). No. of bitstreams: 1 ntu-94-R92443011-1.pdf: 3248808 bytes, checksum: de6e450c477ac9e46c8f2a370d5063f8 (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | 目 錄
縮寫表…………………………………………………1 英文摘要………………………………………………3 中文摘要………………………………………………5 緒論……………………………………………………7 實驗材料及方法………………………………………21 結果……………………………………………………30 討論……………………………………………………55 參考文獻………………………………………………60 | |
dc.language.iso | zh-TW | |
dc.title | 8-Br-AMP於缺血-再灌流後腦損傷之保護作用 | zh_TW |
dc.title | Protective effects of 8-Br-AMP on ischemia/reperfusion-induced brain injury | en |
dc.type | Thesis | |
dc.date.schoolyear | 93-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊春茂,林琬琬,楊榮森 | |
dc.subject.keyword | 缺血性中風,血腦障壁通透性,腦栓塞, | zh_TW |
dc.subject.keyword | ischemia-reperfusion,BBB permeability,Evans blue,ZO-1, | en |
dc.relation.page | 67 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-07-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 3.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。